Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

The junction of the inner and outer prepuce with good blood flow is best for vascular pedicle flaps.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

Hair loss can be an early sign of prostate enlargement.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Androgens may influence bladder cancer progression by affecting cellular behavior.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Men with enlarged prostates often have more severe baldness.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Targeting FGF5 could help treat prostate cancer.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.